Others have similarly shown that TGM2 expression is a prognostic marker in colon cancer and non-small cell lung cancer; and in proteomic profiles, TGM2 upregulation in HCC correlates with early recurrence25–27. The gene discussed is TGM2; the disease is non-small cell lung carcinoma.